HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test gentler drug regimen for risky cancer transplants
Disease control OngoingThis study is testing whether using lower doses of a key drug (cyclophosphamide) and for a shorter time after a stem cell transplant can reduce side effects while still preventing a dangerous complication called graft-versus-host disease (GVHD). It involves people ages 15-65 with…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Doctors test dropping a drug to make cancer transplants safer
Disease control OngoingThis study is testing whether a standard stem cell transplant for blood cancers can be done safely without one of the immune-suppressing drugs (mycophenolate mofetil or MMF). The goal is to see if removing this drug reduces side effects while still controlling the cancer. The tri…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC